North Dakota Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages A North Dakota Collateral License Agreement is a legal contract between Gentling, Inc. and The University of North Texas Health Science Center. This agreement allows Gentling to license certain collateral, such as intellectual property, patents, copyrights, or trademarks from the University for use in their business operations. It outlines the terms and conditions under which the collateral can be used, including any royalties or fees that may be required. The purpose of such an agreement is to provide Gentling with the right to use and commercialize the University's collateral for the development, manufacturing, marketing, and distribution of their products or services. By entering into this agreement, both parties can establish a mutually beneficial relationship that allows for the transfer and utilization of valuable assets. The specific terms and provisions of a North Dakota Collateral License Agreement may vary depending on the nature of the collateral being licensed and the intended purpose. For example, there may be different agreements for licensing patents or copyrights, each tailored to the specific circumstances of the collateral. Some key elements that may be included in a North Dakota Collateral License Agreement are: 1. Grant of License: Gentling is granted a non-exclusive, worldwide license to use the collateral for the specified purposes outlined in the agreement. 2. Restrictions: Certain limitations may be imposed regarding the use of the licensed collateral, such as geographic restrictions or restrictions on sublicensing. 3. Royalties and Payments: The agreement may outline the royalties or fees that Gentling is obligated to pay to the University. These payments may be based on sales, net revenue, or other predetermined criteria. 4. Term and Termination: The agreement will specify the duration of the license and the circumstances under which either party can terminate the agreement. 5. Intellectual Property Ownership: The agreement will clarify the ownership rights of the collateral, ensuring that the University retains its intellectual property rights while granting Gentling the necessary usage rights. It is important to note that the specific naming conventions or types of North Dakota Collateral License Agreements may vary depending on the agreement's structure or the parties involved. For example, there could be separate agreements for licensing patents, copyrights, or trademarks exclusively. Gentling and The University of North Texas Health Science Center may have additional specialized agreements specific to their collaboration or the unique collateral being licensed. Overall, a North Dakota Collateral License Agreement plays a critical role in enabling Gentling to leverage the intellectual property or other collateral assets held by The University of North Texas Health Science Center, facilitating innovation, commercialization, and mutual benefits for both parties involved.

A North Dakota Collateral License Agreement is a legal contract between Gentling, Inc. and The University of North Texas Health Science Center. This agreement allows Gentling to license certain collateral, such as intellectual property, patents, copyrights, or trademarks from the University for use in their business operations. It outlines the terms and conditions under which the collateral can be used, including any royalties or fees that may be required. The purpose of such an agreement is to provide Gentling with the right to use and commercialize the University's collateral for the development, manufacturing, marketing, and distribution of their products or services. By entering into this agreement, both parties can establish a mutually beneficial relationship that allows for the transfer and utilization of valuable assets. The specific terms and provisions of a North Dakota Collateral License Agreement may vary depending on the nature of the collateral being licensed and the intended purpose. For example, there may be different agreements for licensing patents or copyrights, each tailored to the specific circumstances of the collateral. Some key elements that may be included in a North Dakota Collateral License Agreement are: 1. Grant of License: Gentling is granted a non-exclusive, worldwide license to use the collateral for the specified purposes outlined in the agreement. 2. Restrictions: Certain limitations may be imposed regarding the use of the licensed collateral, such as geographic restrictions or restrictions on sublicensing. 3. Royalties and Payments: The agreement may outline the royalties or fees that Gentling is obligated to pay to the University. These payments may be based on sales, net revenue, or other predetermined criteria. 4. Term and Termination: The agreement will specify the duration of the license and the circumstances under which either party can terminate the agreement. 5. Intellectual Property Ownership: The agreement will clarify the ownership rights of the collateral, ensuring that the University retains its intellectual property rights while granting Gentling the necessary usage rights. It is important to note that the specific naming conventions or types of North Dakota Collateral License Agreements may vary depending on the agreement's structure or the parties involved. For example, there could be separate agreements for licensing patents, copyrights, or trademarks exclusively. Gentling and The University of North Texas Health Science Center may have additional specialized agreements specific to their collaboration or the unique collateral being licensed. Overall, a North Dakota Collateral License Agreement plays a critical role in enabling Gentling to leverage the intellectual property or other collateral assets held by The University of North Texas Health Science Center, facilitating innovation, commercialization, and mutual benefits for both parties involved.